Severe vitamin B12 deficiency can lead to other symptoms such as numbness and walking difficulties
In the citation, Michalik compares her work with Furdziks: This part of our work is contained in Section 4
From artificial food dyes to weight-loss injections, there is often a disconnect between what people consume and their understanding of its digestive impact
Twelve-week monotherapy with the DPP-4 inhibitor vildagliptin improves glycemic control in subjects with type 2 diabetes
They come with nasty side effects like nausea, vomiting, diarrhea, and constipation
Drug Class Analysis GLP-1 Weight Loss Drug Market by Drug Class: Injectable and Dual Agonist Therapies Command 78.4% of Revenue Drug Class Revenue Share, CAGR, and Commercial Drivers GLP-1 Obesity Drug Market 2026 Injectable GLP-1 receptor agonist monoagonists hold a 32.8% GLP-1 market revenue share in 2026 , reflecting Wegovys position as the most commercially successful weight management drug in pharmaceutical history